A medical journal has retracted two studies claiming to show the harms of the abortion pill mifepristone, citing conflicts of interest by the authors and flaws in their research.
Two of the three studies retracted by medical publisher Sage Perspectives were cited in a pivotal Texas court ruling that has threatened access to the pill.
The U.S. Supreme Court will take up the case next month, with a decision expected later this year.
Photos You Should See View All 15 ImagesBoth studies cited in the court ruling were published in the journal Health Services Research and Managerial Epidemiology.
She said one of the major flaws of the retracted research is that the authors conflate ER visits with serious adverse events and don’t confirm whether patients received treatment.
Persons:
—, Matthew Kacsmaryk, Sage, James Studnicki, Ivan Oransky, mifepristone
Organizations:
Sage, U.S, Supreme, Health Services Research, Charlotte Lozier Institute, District, New York University, University of California, FDA, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP
Locations:
Texas, U.S, San Francisco